The Global Immunology Market is likely to expand in the coming years driven by the high prevalence of immunological disorders, resulting from environmental factors. According to a report published by Fortune Business Insights, titled “Immunology Market: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 77,365.4 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 143,833.2 Mn by 2026 and will exhibit a CAGR of 8.1%.
some of the key players in the global Immunology market:
- AbbVie Inc.
- Janssen Global Services,
- LLC (Johnson & Johnson)
- Hoffmann-La Roche Ltd
- Amgen Inc.
- Pfizer Inc
- Bristol-Myers Squibb Company
- Merck Sharp & Dohme Corp.
- UCB SA
AbbVie Gains FDA Approval of SKYRIZI; Product to Witness High Demand in No Time
The global immunology market has gained impetus from the availability of several regulatory approved drugs. The approval of new drugs and the trends of improvements in clinical efficiencies will bode well for the global immunology market. In 2019, AbbVie received approval from the Food and Drug Administration (FDA) for the usage of ‘SKYRIZI’. The drug was aimed at the treatment of moderate to severe plaque psoriasis. This drug was inclined towards the treatment of adults diagnosed with psoriasis and have been recommended for or undergoing therapy. The drug is likely to gain huge popularity among healthcare professionals and its high clinical efficacy will fuel the demand in the coming years.
Besides product launches and drug approvals, Fortune Business Insights assesses several other factors that have made significant growth contributions to the global immunology market. Companies are encouraged by the growing usage approvals by regulatory authorities across the world. Several company mergers and acquisitions have also accounted for growth of the global immunology market.
By Drug Class: Monoclonal antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal antibody (pAb), and Others
By Disease Indication: Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, and Others
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
By Geography: North America (U.S., and Canada), Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)
View More Report of Healthcare Category by Fortune Business Insights: